Ameriprise’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-7,622
| Closed | -$734K | – | 4171 |
|
|
2026
Q1 | $734K | Buy |
7,622
+2,757
| +57% | +$276K | ﹤0.01% | 3428 |
|
|
2025
Q4 | $473K | Buy |
4,865
+61
| +1% | +$5.23K | ﹤0.01% | 3644 |
|
|
2025
Q3 | $342K | Buy |
4,804
+32
| +0.7% | +$2.13K | ﹤0.01% | 3753 |
|
|
2025
Q2 | $285K | Sell |
4,772
-1,085
| -19% | -$59.5K | ﹤0.01% | 3711 |
|
|
2025
Q1 | $307K | Sell |
5,857
-12,268
| -68% | -$689K | ﹤0.01% | 3669 |
|
|
2024
Q4 | $997K | Buy |
18,125
+1,792
| +11% | +$94.3K | ﹤0.01% | 3234 |
|
|
2024
Q3 | $821K | Buy |
16,333
+6,615
| +68% | +$305K | ﹤0.01% | 3297 |
|
|
2024
Q2 | $427K | Sell |
9,718
-2,169
| -18% | -$92.2K | ﹤0.01% | 3469 |
|
|
2024
Q1 | $523K | Sell |
11,887
-197
| -2% | -$8.71K | ﹤0.01% | 3398 |
|
|
2023
Q4 | $574K | Buy |
12,084
+126
| +1% | +$5.3K | ﹤0.01% | 3405 |
|
|
2023
Q3 | $531K | Sell |
11,958
-185
| -2% | -$8.6K | ﹤0.01% | 3392 |
|
|
2023
Q2 | $580K | Sell |
12,143
-8,072
| -40% | -$364K | ﹤0.01% | 3383 |
|
|
2023
Q1 | $795K | Buy |
20,215
+3,216
| +19% | +$117K | ﹤0.01% | 3251 |
|
|
2022
Q4 | $481K | Buy |
16,999
+3,499
| +26% | +$100K | ﹤0.01% | 3424 |
|
|
2022
Q3 | $406K | Sell |
13,500
-136
| -1% | -$4.74K | ﹤0.01% | 3468 |
|
|
2022
Q2 | $463K | Sell |
13,636
-6,698
| -33% | -$240K | ﹤0.01% | 3421 |
|
|
2022
Q1 | $912K | Buy |
+20,334
| New | +$940K | ﹤0.01% | 3252 |
|
|
2018
Q3 | – | Sell |
-288,566
| Closed | -$5.99M | – | 3753 |
|
|
2018
Q2 | $5.99M | Sell |
288,566
-181,816
| -39% | -$3.21M | ﹤0.01% | 2122 |
|
|
2018
Q1 | $6.63M | Buy |
470,382
+2,400
| +0.5% | +$34.2K | ﹤0.01% | 1970 |
|
|
2017
Q4 | $7.09M | Buy |
467,982
+11,172
| +2% | +$142K | ﹤0.01% | 1880 |
|
|
2017
Q3 | $4.39M | Buy |
456,810
+113,190
| +33% | +$1.07M | ﹤0.01% | 2177 |
|
|
2017
Q2 | $2.95M | Buy |
+343,620
| New | +$2.93M | ﹤0.01% | 2411 |
|
|
2017
Q1 | – | Sell |
-74,500
| Closed | -$827K | – | 3644 |
|
|
2016
Q4 | $827K | Buy |
74,500
+9,300
| +14% | +$100K | ﹤0.01% | 3047 |
|
|
2016
Q3 | $1.11M | Buy |
65,200
+5,370
| +9% | +$99.4K | ﹤0.01% | 2876 |
|
|
2016
Q2 | $1.3M | Buy |
59,830
+530
| +0.9% | +$9.54K | ﹤0.01% | 2757 |
|
|
2016
Q1 | $1.14M | Buy |
59,300
+24,105
| +68% | +$461K | ﹤0.01% | 2791 |
|
|
2015
Q4 | $987K | Buy |
+35,195
| New | +$995K | ﹤0.01% | 2968 |
|
Other funds holding IRMD
CCM
NTCM
Ameriprise's IRMD Position: Q2 2026 in Review
Ameriprise sold out of iRadimed (IRMD) in Q2 2026, closing a stake of 7,622 shares — an estimated $734K sold.
Ameriprise first reported a position in IRMD in Q4 2015 and held it in 27 quarters. The position peaked at $7.09M in Q4 2017. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.
- Ameriprise reported no remaining iRadimed position as of Q2 2026 after selling out during the quarter.
- Ameriprise sold 7,622 iRadimed shares in Q2 2026, an estimated $734K.
- Ameriprise first reported a position in iRadimed in Q4 2015 and held it in 27 quarters.
- Ameriprise's iRadimed position peaked at $7.09M in Q4 2017.
- 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.
Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.